Understanding how IL-2 cytokine synergizes with PD-1 therapy during chronic viral infection

被引：0
|
作者：
Hashimoto, Masao
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-LB100
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB100
引用
收藏
页数：2
相关论文
共 50 条
  • [1] IL-2 therapy synergizes with PD-L1 blockade to rescue exhausted CD8+T cells during chronic viral infection
    West, Erin
    Ha, Sang-Jun
    Tan, Wendy
    Jin, Hyun-Tak
    Freeman, Gordon
    Smith, Kendall
    Ahmed, Rafi
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [2] Aberrant DNA demethylation of PD-1 during chronic viral infection
    Ben Youngblood
    Oestreich, Kenneth J.
    Ha, Sang-Jun J.
    Duraiswamy, Jaikumar
    Akondy, Rama
    Boss, Jeremy M.
    Ahmed, Rafi
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [3] TLR4 signaling improves PD-1 blockade therapy during chronic viral infection
    Wang, Yidan
    Chung, Young Rock
    Eitzinger, Simon
    Palacio, Nicole
    Gregory, Shana
    Bhattacharyya, Mitra
    Penaloza-MacMaster, Pablo
    PLOS PATHOGENS, 2019, 15 (02)
  • [4] PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells
    West, Erin E.
    Jin, Hyun-Tak
    Rasheed, Ata-Ur
    Penaloza-MacMaster, Pablo
    Ha, Sang-Jun
    Tan, Wendy G.
    Youngblood, Ben
    Freeman, Gordon J.
    Smith, Kendall A.
    Ahmed, Rafi
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (06): : 2604 - 2615
  • [5] Microbial LPS enhances PD-1 therapy during chronic LCMV infection
    Penaloza-MacMaster, Pablo A.
    Wang, Yidan
    Eitzinger, Simon
    Bhattacharyya, Mitra
    Penaloza-MacMaster, Pablo
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [6] Something old, something new: The marriage of PD-1 and IL-2
    Horton, Brendan L.
    Spranger, Stefani
    IMMUNITY, 2023, 56 (01) : 8 - 10
  • [7] IL-2 antibodies in type 1 diabetes and during IL-2 therapy
    Churlaud, Guillaume
    Rosenzwajg, Michelle
    Cacoub, Patrice
    Saadoun, David
    Valteau-Couanet, Dominique
    Chaput, Nathalie
    Pugliese, Alberto
    Klatzmann, David
    DIABETOLOGIA, 2018, 61 (09) : 2066 - 2068
  • [8] IL-2 antibodies in type 1 diabetes and during IL-2 therapy
    Guillaume Churlaud
    Michelle Rosenzwajg
    Patrice Cacoub
    David Saadoun
    Dominique Valteau-Couanet
    Nathalie Chaput
    Alberto Pugliese
    David Klatzmann
    Diabetologia, 2018, 61 : 2066 - 2068
  • [9] IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B
    Chua, Conan
    Salimzadeh, Loghman
    Ma, Ann T.
    Adeyi, Oyedele A.
    Seo, Hobin
    Boukhaled, Giselle M.
    Mehrotra, Aman
    Patel, Anjali
    Ferrando-Martinez, Sara
    Robbins, Scott H.
    La, Danie
    Wong, David
    Janssen, Harry L. A.
    Brooks, David G.
    Feld, Jordan J.
    Gehring, Adam J.
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (12)
  • [10] PD-1 Signaling in HIV and Chronic Viral Infection - Potential for Therapeutic Intervention?
    Eichbaum, Q.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (26) : 3971 - 3980
12345